glp-1 and stroke Risk of major adverse cardiovascular events associated with treatment with or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis GLP-1 Stroke Review Finds Prevention
Description
This is when you lose fat and gain a small amount of muscle at the same time
This applies whether you have used the pen or not
In fact thinning is reported across GLP-1 medicines and is generally a temporary reaction to losing weight quickly rather than a direct drug effect, easing once weight settles
Mimics the complementary effects of diet and exercise, with GLP-1 suppressing appetite and glucagon increasing energy expenditure
Gong N, Fan H, Ma AN, Xiao Q, Wang YX
doi:10.1080/15216540500163301 40
